Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on July 18, 2025
‘The Small Business BIG EXIT’ Launches on Amazon, Offering Strategic Guidance for Business Owners Growth & Exit
EIN Presswire
·
July 18, 2025
The Small Business BIG EXIT is a must-read resource that demystifies what it takes to run your small business into a scalable, fine-tuned, sellable asset. CLEARWATER, FL, UNITED STATES, July 18, 2025 /EINPresswire.com/ -- FOR IMMEDIATE RELEASE …
MOONTON Games partners The Little Black Book Studios and Base Media to develop animated series for Mobile Legends
EIN Presswire
·
July 18, 2025
The series will feature the same award-winning animation team behind Ne Zha 2 SINGAPORE, CHINA, July 18, 2025 /EINPresswire.com/ -- MOONTON Games, the global developer and publisher of the hit mobile Multiplayer Online Battle Arena (MOBA) game Mobile …
Feng Shui Consultant Highlights Common Home Layout Mistakes That May Impact Financial Well-Being
EIN Presswire
·
July 18, 2025
With Rising Financial Anxiety in Hong Kong, Experts Suggest Simple Adjustments to Enhance Positive Energy Flow HONG KONG, HONG KONG, July 18, 2025 /EINPresswire.com/ -- Recent surveys indicate that 58% of Hong Kong residents are cutting expenses due to …
Ditto Transcripts Unveils Surging General Transcription Services Market: 99% Accuracy & Compliant Human‑Powered
EIN Presswire
·
July 18, 2025
Ditto Transcripts reports rapid growth in general transcription, highlighting unmatched 99% accuracy, compliance, and trusted U.S.-based human transcriptionists DENVER, CO, UNITED STATES, July 17, 2025 /EINPresswire.com/ -- Ditto Transcripts, a trusted …
SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
GlobeNewswire
·
July 18, 2025
Data supports further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma. SAN DIEGO, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Sapu Biosciences, LLC (Sapu), a wholly owned …
Successful Commercial Launch of Ryoncil®
GlobeNewswire
·
July 18, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue from sales of Ryoncil® (remestemcel-L-rknd) through the first …